| Rebecca Jo Rosado, MD | |
|
7430 Remcon Cir, Bldg B -110, El Paso, TX 79912-3514 | |
| (915) 544-2455 | |
| (915) 544-3149 |
| Full Name | Rebecca Jo Rosado |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 17 Years |
| Location | 7430 Remcon Cir, El Paso, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063609873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1835 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| O Meara Rosado Dpm Pllc | 2769629336 | 4 |
| Louis E. Zuniga Ptpc | 7618887837 | 85 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity.
Office workers can stave off health problems associated with sitting down all day by regularly exercising, a new study has found.
La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.
Kaiser Health News: "As budget-weary state officials contemplate dropping out of the state-federal Medicaid program, a potentially game-changing question has arisen in Washington: Would poor people who lose Medicaid be eligible for subsidies to buy private coverage in an insurance exchange beginning in 2014? Cindy Mann, director of the federal Center for Medicaid and State Operations, last week said the U.S. Department of Health and Human Services was considering the question.
› Verified 5 days ago
| Provider Name | O Meara Rosado Dpm Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619215365 PECOS PAC ID: 2769629336 Enrollment ID: O20130520000357 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity.
Office workers can stave off health problems associated with sitting down all day by regularly exercising, a new study has found.
La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.
Kaiser Health News: "As budget-weary state officials contemplate dropping out of the state-federal Medicaid program, a potentially game-changing question has arisen in Washington: Would poor people who lose Medicaid be eligible for subsidies to buy private coverage in an insurance exchange beginning in 2014? Cindy Mann, director of the federal Center for Medicaid and State Operations, last week said the U.S. Department of Health and Human Services was considering the question.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Jo Rosado, MD 7430 Remcon Cir, El Paso, TX 79912-3514 Ph: (915) 584-9991 | Rebecca Jo Rosado, MD 7430 Remcon Cir, Bldg B -110, El Paso, TX 79912-3514 Ph: (915) 544-2455 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity.
Office workers can stave off health problems associated with sitting down all day by regularly exercising, a new study has found.
La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.
Kaiser Health News: "As budget-weary state officials contemplate dropping out of the state-federal Medicaid program, a potentially game-changing question has arisen in Washington: Would poor people who lose Medicaid be eligible for subsidies to buy private coverage in an insurance exchange beginning in 2014? Cindy Mann, director of the federal Center for Medicaid and State Operations, last week said the U.S. Department of Health and Human Services was considering the question.
› Verified 5 days ago
Dr. Desiree Dee Webber, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1387 George Dieter Dr Ste 106d, El Paso, TX 79936 Phone: 915-581-0712 | |
Daniel O Mcaffee, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8030 N Loop Dr Bldg C, El Paso, TX 79915 Phone: 915-591-2704 | |
Mr. Caesar A Zuniga, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4646 N Mesa St, El Paso, TX 79912 Phone: 915-313-6300 Fax: 915-521-2028 | |
Dr Charles Pittle Dpm Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 1225 E Cliff Dr, Suite 2a, El Paso, TX 79902 Phone: 915-598-3338 Fax: 915-598-3339 | |
A Plus Foot Care, Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7343 Black Mesa Dr, El Paso, TX 79911 Phone: 915-603-2204 | |
Dr. Bruce Allen Scudday, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1700 Curie Dr, Suite #4000, El Paso, TX 79902 Phone: 915-533-5151 Fax: 915-533-5187 |